Phase I Study of PH100 (Ecklonia Cava Phlorotannins)
Phase 1
Completed
- Conditions
- Safety Issues
- Interventions
- Drug: PlaceboDrug: PH100 100mgDrug: PH100 200mgDrug: PH100 400mgDrug: PH100 800mgDrug: PH100 1200mgDrug: PH100 1600mg
- First Posted Date
- 2020-04-06
- Last Posted Date
- 2020-04-06
- Lead Sponsor
- Phloronol Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04335045
- Locations
- 🇺🇸
Worldwide Clinical Trials Early Phase Services, LLC, San Antonio, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath